Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian B Filion

Showing results (111-120 of 304) with videos related to

Pageof 31
Sort By:
Drug Safety|June 9, 2019
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational StudiesAntonios Douros, Madeleine Durand, Carla M Doyle, et al.
Pharmacoepidemiology and Drug Safety|September 6, 2006
The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research DatabaseKristian B Filion, J A Chris Delaney, James M Brophy, et al.
Diabetes, Obesity & Metabolism|May 11, 2023
Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort studyStéphanie Larose, Christopher Filliter, Robert W Platt, et al.
Journal of Clinical Epidemiology|November 10, 2020
New methodological approaches were able to effectively reduce immeasurable time bias in case-only designsHan Eol Jeong, In-Sun Oh, Hyesung Lee, et al.
Journal of Epidemiology|May 31, 2021
Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control AnalysesHan Eol Jeong, Hyesung Lee, In-Sun Oh, et al.
The American Journal of Cardiology|September 2, 2020
Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary DiseaseJeremy Y Levett, Sarah B Windle, Kristian B Filion, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort studyJenny Dimakos, Ying Cui, Robert W Platt, et al.
Journal of Clinical Epidemiology|May 27, 2026
A Systematic Review of Observational Studies of Sodium-Glucose Cotransporter 2 Inhibitors and COVID-19 Outcomes: A Methodological AssessmentAudray St-Jean, Carolina Moriello, Oriana H Y Yu, et al.
British Journal of Clinical Pharmacology|July 6, 2019
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort studyKristian B Filion, Antonios Douros, Laurent Azoulay, et al.
The American Journal of Cardiology|August 28, 2012
Application of the Seattle heart failure model in patients >80 years of age enrolled in a tertiary care heart failure clinicHanane Benbarkat, Karima Addetia, Mark J Eisenberg, et al.
Pageof 31

Showing results (111-120 of 304) with videos related to

Sort By:
Pageof 31
Drug Safety|June 9, 2019
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational StudiesAntonios Douros, Madeleine Durand, Carla M Doyle, et al.
Pharmacoepidemiology and Drug Safety|September 6, 2006
The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research DatabaseKristian B Filion, J A Chris Delaney, James M Brophy, et al.
Diabetes, Obesity & Metabolism|May 11, 2023
Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort studyStéphanie Larose, Christopher Filliter, Robert W Platt, et al.
Journal of Clinical Epidemiology|November 10, 2020
New methodological approaches were able to effectively reduce immeasurable time bias in case-only designsHan Eol Jeong, In-Sun Oh, Hyesung Lee, et al.
Journal of Epidemiology|May 31, 2021
Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control AnalysesHan Eol Jeong, Hyesung Lee, In-Sun Oh, et al.
The American Journal of Cardiology|September 2, 2020
Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary DiseaseJeremy Y Levett, Sarah B Windle, Kristian B Filion, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort studyJenny Dimakos, Ying Cui, Robert W Platt, et al.
Journal of Clinical Epidemiology|May 27, 2026
A Systematic Review of Observational Studies of Sodium-Glucose Cotransporter 2 Inhibitors and COVID-19 Outcomes: A Methodological AssessmentAudray St-Jean, Carolina Moriello, Oriana H Y Yu, et al.
British Journal of Clinical Pharmacology|July 6, 2019
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort studyKristian B Filion, Antonios Douros, Laurent Azoulay, et al.
The American Journal of Cardiology|August 28, 2012
Application of the Seattle heart failure model in patients >80 years of age enrolled in a tertiary care heart failure clinicHanane Benbarkat, Karima Addetia, Mark J Eisenberg, et al.
Pageof 31